Frequency of Post-stroke Fatigue and Its Relationship With Clinical Parameters

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

This study aims to determine the frequency of post-stroke fatigue (PSF) in patients experiencing their first-ever stroke and admitted to our clinic. PSF is a common and debilitating condition that significantly impacts patients' recovery and quality of life. The study will also explore the association between fatigue severity and various demographic and clinical factors such as age, gender, stroke type and duration, pain, mood disorders, sleep quality, motor and cognitive functions, spasticity, physical capacity, ambulation, independence in daily living activities, and health-related quality of life. Patients over 18 years old, at least three months post-stroke, and meeting specific inclusion criteria will be recruited. Fatigue will be assessed using validated scales including the Fatigue Severity Scale and Visual Analog Scale-Fatigue. Additional assessments will measure pain, anxiety, depression, sleep disturbances, motor and cognitive status, spasticity, physical endurance, functional mobility, and daily activity independence. The findings are expected to contribute to a better understanding of PSF and help inform more effective rehabilitation strategies.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Being diagnosed with stroke according to definition by the World Health Organization

• Being over 18 years of age

• Having had a stroke confirmed by Computed Tomography (CT) and/or Magnetic Resonance Imaging (MRI)

• At least 3 months after stroke

• At least stage 2 according to the Functional Ambulation Classification

• Agreed to participate in the study and signed the informed consent form

Locations
Other Locations
Turkey
Ankara University
RECRUITING
Ankara
Contact Information
Primary
Mehmet Tekeş, MD
yusuf1tekes@gmail.com
+903125082822
Backup
Ayşe A. Küçükdeveci, MD, Prof
ayse.kucukdeveci@gmail.com
+903125082822
Time Frame
Start Date: 2024-11-21
Estimated Completion Date: 2026-01-29
Participants
Target number of participants: 107
Related Therapeutic Areas
Sponsors
Leads: Ankara University

This content was sourced from clinicaltrials.gov